Coronary vasodilators
Koronarni vazodilatatori
dc.creator | Stepanović-Petrović, Radica | |
dc.date.accessioned | 2019-09-02T11:15:31Z | |
dc.date.available | 2019-09-02T11:15:31Z | |
dc.date.issued | 2008 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/1152 | |
dc.description.abstract | Ischemic heart disease is a condition in which there is an inadequate supply of blood and oxygen to a portion of a myocardium. It typically occurs when there is an imbalance between myocardial oxygen supply and demand. The most common cause of myocardial ischemia is atherosclerotic disease of an epicardial coronary artery (or arteries) sufficient to cause a regional reduction in myocardial blood flow and inadequate perfusion of the myocardium supplied by the involved coronary artery. In the treatment of angina pectoris, which is one of the manifestation of ischemic heart disease, among the other drugs used are so cold 'coronary vasodilators' which included organic nitrates and Ca+2 channel antagonists. This paper presents these drugs, by giving the main information about their mechanisms of action, pharmacokinetic characteristics, side effects and interactions with the other drugs. | en |
dc.description.abstract | Ishemijska bolest srca je oboljenje kod koga postoji neadekvatno snabdevanje izvesnih delova srca krvlju i kiseonikom. Bolest se manifestuje kada se pojavi nesklad između mogućnosti snabdevanja srca kiseonikom i potreba miokarda za njim. Najčešći uzrok ishemije srca je ateroskleroza epikardijalne koronarne arterije (ili arterija), koja je takva da izaziva regionalnu redukciju protoka krvi kroz srce i neadekvatnu perfuziju tog dela miokarda. U lečenju angine pektoris, koja predstavlja jednu od manifestacija ishemijske bolesti srca, među ostalim lekovima koriste se i tzv. 'koronarni vazodilatatori' u koje se ubrajaju organski nitrati i blokatori kalcijumovih (Ca+2) kanala. Rad prikazuje ove lekove, dajući osnovne informacije o njihovim mehanizmima dejstva, farmakokinetičkim karakteristikama, neželjenim efektima i interakcijama sa drugim lekovima. | sr |
dc.publisher | Savez farmaceutskih udruženja Srbije, Beograd | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | |
dc.subject | angina pectoris | en |
dc.subject | organic nitrates | en |
dc.subject | tolerance | en |
dc.subject | Ca+2channel antagonists | en |
dc.subject | angina pektoris | sr |
dc.subject | organski nitrati | sr |
dc.subject | tolerancija | sr |
dc.subject | blokatorikalcijumovih (Ca+2) kanala | sr |
dc.title | Coronary vasodilators | en |
dc.title | Koronarni vazodilatatori | sr |
dc.type | article | |
dc.rights.license | BY-SA | |
dcterms.abstract | Степановић-Петровић, Радица; Коронарни вазодилататори; Коронарни вазодилататори; | |
dc.citation.volume | 58 | |
dc.citation.issue | 5-6 | |
dc.citation.spage | 324 | |
dc.citation.epage | 333 | |
dc.citation.other | 58(5-6): 324-333 | |
dc.identifier.fulltext | https://farfar.pharmacy.bg.ac.rs//bitstream/id/121/1150.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_1152 | |
dc.type.version | publishedVersion |